✦ LIBER ✦

453 PITAVASTATIN PROVIDES CONSISTENT LONG-TERM HDL-CHOLESTEROL IMPROVEMENTS IN A RANGE OF PATIENTS WITH DYSLIPIDAEMIA: RESULTS FROM A PHASE III STUDY PROGRAMME

✍ Scribed by Hounslow, N.

Book ID: 118639460
Publisher: Elsevier Science
Year: 2011
Tongue: English
Weight: 60 KB
Volume: 12
Category: Article
ISSN: 1567-5688
DOI: 10.1016/s1567-5688(11)70454-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

254 PITAVASTATIN HAS PLEIOTROPIC ANTI-OX

254 PITAVASTATIN HAS PLEIOTROPIC ANTI-OXIDATIVE AND ANTIINFLAMMATORY BENEFITS IN PATIENTS WITH DYSLIPIDAEMIA: RESULTS FROM A PHASE III STUDY PROGRAMME

✍ Hounslow, N. 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 43 KB

Adding androgen suppression to radiother

Adding androgen suppression to radiotherapy may improve disease-free survival over radiotherapy alone in locally advanced prostate cancer: Abstracted from: Bolla M, Collette L, Blank L et al. Long-term results with immediate androgen suppression and external irradiation in patients with locally advanced prostate cancer (an EORTC study): a phase III randomised trial. Lancet 2002; 360: 103–6.

✍ John B Fiveash 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 71 KB

Phase 2 trial of primary systemic therap

Phase 2 trial of primary systemic therapy with doxorubicin and docetaxel followed by surgery, radiotherapy, and adjuvant chemotherapy with cyclophosphamide, methotrexate, and 5-fluorouracil based on clinical and pathologic response in patients with stage IIB to III breast cancer : Long-term results from The University of Texas M. D. Anderson Cancer Center Study ID97-099

✍ Ricardo H. Alvarez; Daniel J. Booser; Massimo Cristofanilli; Aysegul A. Sahin; E 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 199 KB 👁 2 views